Mid-level vision

Barton L. Anderson

doi:10.1016/j.cub.2019.11.088

Return

Mid-level vision

2020-02-01

Barton L. Anderson *

DOI：10.1016/j.cub.2019.11.088

Original

Save

View PDF

Abstract

Keywords:

PERCEPTION

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Current Biology

IF:

7.5

Papers:

2.2W

Citations:

7.8W

Organization

University of Sydney

Scholars:

6.5W

Papers: 6.2W

Citations: 90

Cited Papers

Randomized Phase 2 Study of Weekly Carfilzomib 70 Mg/m2 and Dexamethasone Plus/Minus Cyclophosphamide in Relapsed and/or Refractory Multiple Myeloma (RRMM) Patients (GEM-KyCyDex)

Blood

IF0

2020-11-05

OAAI

Maria-Victoria Mateos; Enrique M. Ocio; Anna Sureda Balari; Albert Oriol; Esther González Garcia; Maria José Moreno; Miquel Granell; Fernando Escalante; Veronica Gonzalez De La Calle; Laura Rosinol Dachs; Estrella Carrillo-Cruz; Joaquín Martínez-López; Maria Victoria Dourdil Sahun; Marta Sonia Gonzalez; Jaime Perez De Oteyza; Felipe De Arriba; Miguel T Hernández; Aránzazu García Mateo; Ana Pilar Gonzalez; Rafael Rios; Carmen Cabrera; Juan Jose Bargay; Paula Rodriguez-Otero; Felipe Casado; Maria Casanova; María Jesús Blanchard; Joan Blade Creixenti; Juan Jose Lahuerta; Jesus F. San-Miguel

Save

Erythrophagocytose et recyclage du fer héminique dans les conditions normales et pathologiques ; régulation par l'hepcidine

Transfusion Clinique et Biologique

IF0

2005-06-01

PREAI

C. Beaumont; F. Canonne-Hergaux

Save

Phase I/II study of R-ICE (rituximab-ifosfamide-carboplatin-etoposide) with lenalidomide (R2-ICE) in patients with first-relapse/primary refractory diffuse large B-cell lymphoma (DLBCL) in academic and community cancer research united (ACCRU) network.

Journal of Clinical Oncology

IF0

2020-05-20